Correlation of Pharmacological Properties of a Group of Hypolipaemic Drugs by Molecular Topology
- 1 March 1996
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 48 (3) , 240-244
- https://doi.org/10.1111/j.2042-7158.1996.tb05909.x
Abstract
This investigation was undertaken to test the ability of the molecular connectivity model to predict the percentage of plasma protein binding, the percentage of total cholesterol reduction and oral LD50 in rats of a group of hypolipaemic drugs using multi‐variable regression equations with multiple correlation coefficients, standard error of estimate, degrees of freedom, F‐Snedecor function values, Mallow's CP and Student's t‐test as criteria of fit. Regression analyses showed that the molecular connectivity model predicts these properties. Corresponding stability (cross validation) studies were made on the selected prediction models which confirmed their goodness of fit. The results also demonstrated that the presence of substituents and molecular volume, determine the value of these properties in hypolipaemic drugs.Keywords
This publication has 9 references indexed in Scilit:
- Low density lipoprotein density and composition in hypercholesterolaemic men treated with HMG CoA reductase inhibitors and gemfibrozilJournal of Internal Medicine, 1991
- Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductaseEuropean Journal of Clinical Pharmacology, 1991
- Use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in various forms of dyslipidemiaThe American Journal of Cardiology, 1990
- Drug Treatment of DyslipoproteinemiaEndocrinology and Metabolism Clinics of North America, 1990
- Lovastatin and Simvastatin - Inhibitors of HMG CoA Reductase and Cholesterol BiosynthesisCardiology, 1990
- Pharmacokinetic Drug Data1Clinical Pharmacokinetics, 1988
- BezafibrateDrugs, 1987
- Characterization of molecular branchingJournal of the American Chemical Society, 1975